ValueBuddies.com : Value Investing Forum - Singapore, Hong Kong, U.S.

Pages (766): « Previous 1 … 736 737 738 739 740 … 766 Next »

Date & Time	Title
Tue, 10 Dec 2024 22:00:00 +0800	DL E&C Marks First Entry into Canadian Blue Ammonia Market
Tue, 10 Dec 2024 22:00:00 +0800	Next Level Aviation® Secures $50MM Credit Facility with PNC Bank
Tue, 10 Dec 2024 21:48:00 +0800	State Grid Kashgar Power Supply Company: Special investigation on hidden dangers of electric bicycle charging
Tue, 10 Dec 2024 21:46:00 +0800	State Grid Kashgar Power Supply Company: Successfully Passed Assessment for AC and DC Charging Pile and Combined Transformer Calibration
Tue, 10 Dec 2024 21:42:00 +0800	Global Schools Group Opens One World International Digital Campus, Pioneering Digital and Sustainable Education in Singapore
Tue, 10 Dec 2024 21:41:00 +0800	2024 Understanding China Conference Concludes Successfully: A New Path for Global Understanding of Chinese Modernization
Tue, 10 Dec 2024 21:34:00 +0800	Live from ASH 2024 \| 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminib
Tue, 10 Dec 2024 21:30:00 +0800	Live from ASH 2024 \| Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in Combinations Demonstrates Potential Clinical Benefit in Patients with Prior Exposure to Venetoclax
Tue, 10 Dec 2024 21:29:00 +0800	The new battleground for commercial card providers: Rewards and flexibility, Ascenda report reveals
Tue, 10 Dec 2024 21:27:00 +0800	Live from ASH 2024 \| First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Report
Tue, 10 Dec 2024 21:26:00 +0800	Live from ASH 2024 \| 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminib
Tue, 10 Dec 2024 21:00:00 +0800	Bring Christmas Cheer to Your Home with Yaber Projectors: Holiday Sale Now Live on Amazon
Tue, 10 Dec 2024 21:00:00 +0800	Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular Care
Tue, 10 Dec 2024 21:00:00 +0800	Hohem iSteady M7, the Ultimate AI Gimbal for Mobile Filmmaking
Tue, 10 Dec 2024 21:00:00 +0800	Waters Highlights Continued Progress Towards Sustainability Commitments
Tue, 10 Dec 2024 20:55:00 +0800	Stellantis and CATL to Invest Up to €4.1 Billion in Joint Venture for Large-Scale LFP Battery Plant in Spain
Tue, 10 Dec 2024 20:55:00 +0800	State Grid Xuzhou Power Supply Company: Helping to boost the "green content" of industrial development
Tue, 10 Dec 2024 20:48:00 +0800	Live from ASH 2024 \| First Dataset of Olverembatinib in Combination with Bcl-2 Inhibitor Lisaftoclax Demonstrates Potential Clinical Benefits as a Chemotherapy-Free Regimen for Children with R/R Ph+ ALL
Tue, 10 Dec 2024 20:42:00 +0800	District neighboring Hong Kong attracts global investment for commerce, trade, and cultural tourism
Tue, 10 Dec 2024 20:07:00 +0800	Noah Holdings 2024 Corporate Open Day: Driving Global Expansion and Sophisticated Solutions for Mandarin-Speaking Clients

Pages (766): « Previous 1 … 736 737 738 739 740 … 766 Next »

Login
Username:
Password:	Lost Password?
	Remember me